
|Articles|September 27, 2007
DEA: Marijuana-related generic drugs belong under Schedule III
Generic versions of Marinol should be classified as Schedule III when they are approved, according to the Drug Enforcement Administration
Advertisement
Because generic versions of Marinol (dronabinol, Solvay Pharmaceuticals) are in development, DEA is proposing to put these upcoming products that contain tetrahydrocannabinols (THC), when approved, under the same classification of Schedule III. THC is believed to be the major psychoactive component of the cannabis (marijuana) plant. This DEA proposal was published in the Sept. 24
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs
2
Heat and Pregnancy: What Pharmacists Need to Know
3
Q&A: PBMs Use Audits to Generate Revenue Amid Unprecedented Scrutiny
4
"It is the Core of Our Oath:" Why Gender-Affirming Care Is a Fundamental Pharmacy Mandate
5







































